Muhammad Aqib Faizan: New Evidence Supports Optimized Riociguat Use in Pulmonary Hypertension
Muhammad Aqib Faizan, Clinical Intern at District Headquarter Hospital, MTI, DIKhan, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Medicine, adding:
“Check out our systematic review and meta-analysis published in Medicine Journal.
Optimizing Riociguat Therapy for Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Dose Variability, Safety, and Efficacy
I’m proud to have led this collaborative international research effort focused on improving outcomes in patients with pulmonary hypertension.
Key Findings:
- Riociguat significantly improved 6-minute walk distance
- Reduced mean pulmonary arterial pressure
- Lowered pulmonary vascular resistance
- Decreased NT-proBNP levels
- The 2.5 mg three-times-daily dose showed the most consistent benefit
Our findings support personalized dosing strategies to optimize efficacy and safety in pulmonary hypertension management.
Grateful to all my co-authors and mentors for their dedication and teamwork throughout this journey.”
Title: Optimizing riociguat therapy for pulmonary hypertension: A systematic review and meta-analysis of dose variability, safety, and efficacy
Auhtors: Faizan Muhammad Aqib, Rehman Tooba, Malik Hurais, Hudaib Muhammad, Tahir Muhammad Abdullah, Ohri Gunvi, Bano Saher, Fatima Laveeza, Ahmed Syed Hassan, Karam Ayat ul, Ahmed Zuhair, Rehman Abdul, Rabbani Samra, Dandamudi Mrunalini, Mahmmoud Fadelallah Eljack Mohammed, Humayun Zainab

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics